The antitumor response of NMD inhibition was dependent on the immune system, as tumor kinetics of 4T1 SMG1KD was similar to the control when implanted in immunodeficient mice (Rag2/IL2rg-/-) (Fig. S3E-F). The gene discussed is RAG2; the disease is neoplasm.